NNPA NEWSWIRE — As you may have heard, my team at Pfizer recently experienced a significant disappointment. Our phase 3 trial for rivipansel, a potential treatment...
(Morning Ticker) – Recently we reported on the FDA’s decision to approve Entresto, a new drug from Novartis that has shown an astonishing 20 percent reduction...
(Forbes) – It used to be that the major hurdle in getting a new drug approved was successfully completing phase 3 trials – the long-term...
(Forbes) – It used to be that the major hurdle in getting a new drug approved was successfully completing phase 3 trials – the long-term...
(Reuters) – U.S. regulators on Friday gave a green light to sales of the country’s first “biosimilar,” or copied version of a biotechnology drug, by approving Novartis’ white...
(Bloomberg) – Novartis AG applied for U.S. regulatory approval for two drugs to treat smoker’s cough that analysts estimate could generate an additional $1.4 billion in annual...
(Bloomberg) – Novartis AG applied for U.S. regulatory approval for two drugs to treat smoker’s cough that analysts estimate could generate an additional $1.4 billion in annual...